What does this test include?
This test measures CD33-positive myeloid cell counts in EDTA blood, performed with accuracy by Metropolis Healthcare.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses flow cytometry to detect and quantify CD33 expression on myeloid cells.
Who should take this test?
Patients with suspected myeloid leukemia or abnormal blood/marrow findings can benefit at Metropolis Healthcare.
Why is CD33 testing important?
Metropolis Healthcare uses this test to identify myeloid lineage involvement and support disease classification.
Do I need to fast before this test?
No fasting is required; Metropolis Healthcare only needs an EDTA blood sample.
What do high CD33 counts indicate?
High counts at Metropolis Healthcare may suggest myeloid proliferation or leukemia.
What do low CD33 counts mean?
Low levels at Metropolis Healthcare can reflect reduced myeloid activity or marrow suppression.
How long does it take to get results?
Metropolis Healthcare ensures timely and accurate results to support effective clinical decision-making.